{"id":90975,"date":"2025-10-19T17:26:08","date_gmt":"2025-10-19T17:26:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/90975\/"},"modified":"2025-10-19T17:26:08","modified_gmt":"2025-10-19T17:26:08","slug":"ozempic-at-costco-discount-giant-expands-into-100-billion-weight-loss-drug-market","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/90975\/","title":{"rendered":"Ozempic at Costco? Discount Giant Expands Into $100 Billion Weight-Loss Drug Market"},"content":{"rendered":"\n<p class=\"yf-1090901\">Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.<\/p>\n<p class=\"yf-1090901\">Costco (NASDAQ:<a class=\"link \" href=\"https:\/\/www.benzinga.com\/quote\/COST?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=real_estate&amp;nid=48293648\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:COST;elm:context_link;itc:0;sec:content-canvas\">COST<\/a>), the warehouse club best known for its bulk bargains and $1.50 hot dogs, is expanding its pharmacy into fast-growing weight-loss drug market. The company is now selling Ozempic and Wegovy \u2014 two of the most in-demand prescription medications in the U.S. \u2014 at its pharmacies nationwide.<\/p>\n<p class=\"yf-1090901\">Novo Nordisk (NYSE:<a class=\"link \" href=\"https:\/\/www.benzinga.com\/quote\/NVO?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=real_estate&amp;nid=48293648\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:NVO;elm:context_link;itc:0;sec:content-canvas\">NVO<\/a>), the Danish pharmaceutical company behind both medications, announced that Costco will now offer a one-month supply of <a href=\"https:\/\/www.benzinga.com\/markets\/large-cap\/25\/10\/48084500\/wegovy-ozempic-maker-novo-nordisk-cuts-staff-at-key-us-production-sites?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=real_estate&amp;nid=48293648\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Ozempic;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Ozempic<\/a> or Wegovy for $499. The price matches what Novo Nordisk lists on its direct-to-consumer website and what&#8217;s available through CVS and Walmart.<\/p>\n<p class=\"yf-1090901\">Don&#8217;t Miss:<\/p>\n<p class=\"yf-1090901\">That&#8217;s a major markdown compared with typical retail prices of around $1,300 for Ozempic and $1,600 for Wegovy, according to <a href=\"https:\/\/www.goodrx.com\/ozempic\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:GoodRx;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">GoodRx<\/a>. Both drugs are part of a class known as GLP-1 agonists \u2014 injectable medications that can help regulate blood sugar and suppress appetite. Ozempic is approved to treat Type 2 diabetes, while Wegovy is FDA-approved for chronic weight management.<\/p>\n<p class=\"yf-1090901\">The new program is available at more than 600 Costco pharmacies across the U.S. Members will still need a prescription to purchase either medication. Executive members and Costco Citibank Visa cardholders can also earn 2% cash back on their purchases through the retailer&#8217;s rewards program.<\/p>\n<p class=\"yf-1090901\">David Moore, executive vice president for Novo Nordisk&#8217;s U.S. operations, said the partnership is intended to make access easier.<\/p>\n<p class=\"yf-1090901\">&#8220;Our collaboration with Costco is another step forward by Novo Nordisk in making real Wegovy and Ozempic easier to access and afford \u2013 right where people already shop,&#8221; Moore said in a statement. &#8220;By partnering with one of the country&#8217;s most trusted retailers, we are meeting people where they are and connecting them to real, FDA-approved medicines in our premium pen devices with our $499 self-pay offer. Everyone deserves care that&#8217;s simple, reliable, and within reach \u2013 and we&#8217;re proud to lead the way in helping make that a reality.&#8221;<\/p>\n<p class=\"yf-1090901\">Trending: If there was a new fund backed by Jeff Bezos offering a <a href=\"https:\/\/arrivedhomes.go2cloud.org\/aff_c?offer_id=8&amp;aff_id=1006&amp;aff_sub=yahoo\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:7-9% target yield with monthly dividends would you invest in it;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">7-9% target yield with monthly dividends would you invest in it<\/a>?<\/p>\n<p class=\"yf-1090901\">It&#8217;s not just Costco offering that $499 mark. <a href=\"https:\/\/www.novonordisk-us.com\/media\/news-archive\/news-details.html?id=916418\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Novo Nordisk;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Novo Nordisk<\/a> in August lowered the price of Ozempic for self-paying patients to $499 per month.<\/p>\n<p class=\"yf-1090901\">One prefilled 2 mg pen of Ozempic or four prefilled 0.25 mg pens of Wegovy are also currently available for $499 via a coupon through GoodRx. This matches the Costco price, effectively giving patients that option through an online discount channel.<\/p>\n<p class=\"yf-1090901\">That GoodRx pricing helps underscore how manufacturers and retail partners are trying to standardize a lower &#8220;cash-pay&#8221; price for <a href=\"https:\/\/www.benzinga.com\/news\/health-care\/25\/09\/47593851\/wegovy-and-zepbound-cost-effective-but-they-could-break-drug-budgets?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=real_estate&amp;nid=48293648\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:semaglutide medications;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">semaglutide medications<\/a> in the U.S.<\/p>\n<p class=\"yf-1090901\">While the $499 monthly price may expand access for people without insurance, medical experts told <a href=\"https:\/\/www.nbcnews.com\/health\/health-news\/costco-ozempic-wegovy-discount-insurance-rcna235471\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:NBC News;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">NBC News<\/a> that the medications will still be out of reach for many. &#8220;This will definitely improve one of the issues with access,&#8221; said Dr. Rekha Kumar, an endocrinologist at Weill Cornell Medicine. &#8220;But it will not solve the issues of insurance coverage and cost.&#8221;<\/p>\n<p class=\"yf-1090901\">See Also: Missed Nvidia and Tesla? RAD Intel Could Be the Next AI Powerhouse \u2014<a href=\"https:\/\/www.benzinga.com\/money\/rad-intel-reg-a-y2?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=real_estate&amp;nid=48293648\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Invest Now at Just $0.81 a Share;elm:context_link;itc:0;sec:content-canvas\" class=\"link \"> Invest Now at Just $0.81 a Share<\/a><\/p>\n<p class=\"yf-1090901\">Only 13 states currently cover GLP-1 drugs for obesity treatment under Medicaid, according to the nonprofit health research group KFF. Many private insurance plans also exclude these prescriptions, leaving patients to pay out of pocket.<\/p>\n<p class=\"yf-1090901\">Dr. Harlan Krumholz, a cardiologist and professor at Yale School of Medicine, told NBC News that while increased availability is a positive step, affordability remains a barrier. &#8220;The people who have the greatest need for these medications are precisely the people who have either poor insurance or no insurance,&#8221; he said.<\/p>\n<p class=\"yf-1090901\">The move highlights Costco&#8217;s growing presence in the health sector. As weight-loss medications continue to reshape consumer health spending, Costco&#8217;s partnership with Novo Nordisk positions the retailer to play a larger role in how Americans access \u2014 and afford \u2014 these blockbuster drugs.<\/p>\n<p class=\"yf-1090901\">Read Next: Backed by $300M+ in Assets and Microsoft&#8217;s Climate Fund, <a href=\"https:\/\/www.benzinga.com\/money\/farmland-lp-y2?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=real_estate&amp;nid=48293648\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Farmland LP Opens Vital Farmland III to Accredited Investors;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Farmland LP Opens Vital Farmland III to Accredited Investors<\/a><\/p>\n<p class=\"yf-1090901\">Image: Shutterstock<\/p>\n<p class=\"yf-1090901\">This article <a href=\"https:\/\/www.benzinga.com\/markets\/25\/10\/48293648\/ozempic-at-costco-discount-giant-expands-into-100-billion-weight-loss-drug-market?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=real_estate\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Ozempic at Costco? Discount Giant Expands Into $100 Billion Weight-Loss Drug Market;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Ozempic at Costco? Discount Giant Expands Into $100 Billion Weight-Loss Drug Market<\/a> originally appeared on <a href=\"https:\/\/www.benzinga.com\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Benzinga.com;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Benzinga.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Costco&hellip;\n","protected":false},"author":2,"featured_media":90976,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[36073,6791,103,397,396,61,60,10416,4370,57736,27297,11496],"class_list":["post-90975","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-accredited-investors","tag-costco","tag-health","tag-health-care","tag-healthcare","tag-ie","tag-ireland","tag-novo-nordisk","tag-ozempic","tag-pharmaceutical-company","tag-prescription-medications","tag-weight-loss-drug"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/90975","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=90975"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/90975\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/90976"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=90975"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=90975"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=90975"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}